Cargando…
Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders
Abnormal levels of kynurenic acid (KYNA) in the human brain are believed to be connected to several central nervous system (CNS) diseases, therefore compounds which affect the production of this crucial metabolite are of interest in CNS drug development. The majority of KYNA production is accounted...
Autores principales: | Nematollahi, Alireza, Sun, Guanchen, Jayawickrama, Gayan S., Hanrahan, Jane R., Church, W. Bret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273595/ https://www.ncbi.nlm.nih.gov/pubmed/27367665 http://dx.doi.org/10.3390/molecules21070856 |
Ejemplares similares
-
Kynurenine Aminotransferase Isozyme Inhibitors: A Review
por: Nematollahi, Alireza, et al.
Publicado: (2016) -
Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters
por: Jayawickrama, Gayan S., et al.
Publicado: (2018) -
Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives
por: Jayawickrama, Gayan S., et al.
Publicado: (2017) -
Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 Å Resolution
por: Nematollahi, Alireza, et al.
Publicado: (2016) -
KatG-Mediated Oxidation Leading to Reduced Susceptibility
of Bacteria to Kanamycin
por: Loewen, Peter C., et al.
Publicado: (2018)